Fractyl Health, Inc. financial data

Symbol
GUTS on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
3 Van De Graaff Drive, Suite 200, Burlington, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
Fractyl Laboratories Inc. (to 3/19/2020)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 47.9M shares
Common Stock, Shares, Outstanding 47.9M shares
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 47.9M shares +2206%
Weighted Average Number of Shares Outstanding, Diluted 47.9M shares +2206%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue 24K USD -48.9%
Research and Development Expense 16.8M USD +83.4%
Operating Income (Loss) -23M USD -93.6%
Nonoperating Income (Expense) 5.76M USD
Net Income (Loss) Attributable to Parent -17.2M USD +43%
Earnings Per Share, Basic -0.36 USD/shares +97.8%
Earnings Per Share, Diluted -0.36 USD/shares +97.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 102M USD
Accounts Receivable, after Allowance for Credit Loss, Current 22K USD
Inventory, Net 64K USD
Assets, Current 107M USD
Property, Plant and Equipment, Net 3.17M USD
Operating Lease, Right-of-Use Asset 29.2M USD
Other Assets, Noncurrent 3.3M USD
Assets 146M USD
Accounts Payable, Current 2.29M USD
Liabilities, Current 14.3M USD
Operating Lease, Liability, Noncurrent 28M USD
Other Liabilities, Noncurrent 964K USD
Liabilities 75.7M USD
Retained Earnings (Accumulated Deficit) -367M USD
Stockholders' Equity Attributable to Parent 70.8M USD
Liabilities and Equity 146M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -11.7M USD -22.6%
Net Cash Provided by (Used in) Financing Activities 101M USD
Net Cash Provided by (Used in) Investing Activities -1.06M USD -5195%
Common Stock, Shares Authorized 300M shares
Common Stock, Shares, Issued 47.9M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 88.2M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 107M USD +232%
Interest Paid, Excluding Capitalized Interest, Operating Activities 621K USD
Depreciation 53K USD -33.8%
Payments to Acquire Property, Plant, and Equipment 1.06M USD +5195%
Lessee, Operating Lease, Liability, to be Paid 60.9M USD
Operating Lease, Liability, Current 4.88M USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.98M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 5.82M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.78M USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.74M USD
Additional Paid in Capital 438M USD
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 3.79M USD +253%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares